We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $164B
1-Year Est. Return 112.45%
This Fund
S&P 500
This Quarter Est. Return
+1.02%
1 Year Est. Return
+112.45%
3 Year Est. Return
+265.66%
5 Year Est. Return
+320.52%
10 Year Est. Return
+867.59%
AUM
$12.6B
AUM Growth
-$409M
Cap. Flow
-$304M
Cap. Flow %
-2.41%
Top 10 Hldgs %
25.36%
Holding
834
New
37
Increased
442
Reduced
281
Closed
71

Top Buys

Rank Stock Value
1
CF icon
CF Industries
CF
+$88.6M
2
BTG icon
B2Gold
BTG
+$55.1M
3
KSU
Kansas City Southern
KSU
+$39.3M
4
SE
Spectra Energy Corp Wi
SE
+$38.9M
5
PTEN icon
Patterson-UTI
PTEN
+$37.5M

Top Sells

Rank Stock Value
1
CMI icon
Cummins
CMI
+$78.5M
2
FNV icon
Franco-Nevada
FNV
+$57.5M
3
AEM icon
Agnico Eagle Mines
AEM
+$54.9M
4
DIS icon
Walt Disney
DIS
+$41.1M
5
AMAT icon
Applied Materials
AMAT
+$40.3M

Sector Composition

Rank Sector Weight
1 Materials 42.78%
2 Energy 28.26%
3 Healthcare 9.74%
4 Industrials 4.39%
5 Technology 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSM icon
126
Fortuna Silver Mines
FSM
$3.44B
$21.4M 0.17%
9,518,906
+628,958
+7% +$1.57M
IQV icon
127
IQVIA
IQV
$43.1B
$21.1M 0.17%
306,774
+39,886
+15% +$2.73M
RDC
128
DELISTED
Rowan Companies Plc
RDC
$20.6M 0.16%
1,217,923
+118,048
+11% +$2.26M
UTHR icon
129
United Therapeutics
UTHR
$21.3B
$20.4M 0.16%
130,496
+26,364
+25% +$3.84M
DO
130
DELISTED
Diamond Offshore Drilling
DO
$19.8M 0.16%
940,094
+103,998
+12% +$2.19M
PFE icon
131
Pfizer
PFE
$158B
$19.6M 0.16%
641,541
+56,465
+10% +$1.78M
CDE icon
132
Coeur Mining
CDE
$20.4B
$19.6M 0.16%
7,901,012
+155,499
+2% +$425K
HMY icon
133
Harmony Gold Mining
HMY
$12.3B
$19M 0.15%
20,458,479
-5,151,442
-20% -$3.76M
ALKS icon
134
Alkermes
ALKS
$7.69B
$19M 0.15%
239,100
+31,352
+15% +$2.2M
CNH
135
CNH Industrial
CNH
$22.1B
$18.9M 0.15%
3,181,365
-443,944
-12% -$2.68M
QGENF
136
DELISTED
QIAGEN NV
QGENF
$18.6M 0.15%
673,047
+85,674
+15% +$2.37M
NVO
137
Novo Nordisk
NVO
$192B
$18.6M 0.15%
638,836
+41,724
+7% +$1.15M
AGN
138
DELISTED
Allergan plc
AGN
$18.5M 0.15%
59,150
+2,671
+5% +$795K
GSK icon
139
GSK
GSK
$100B
$18.5M 0.15%
366,340
+31,957
+10% +$1.63M
SNY icon
140
Sanofi
SNY
$104B
$18.4M 0.15%
430,546
+95,338
+28% +$4.39M
ALNY icon
141
Alnylam Pharmaceuticals
ALNY
$33.5B
$18.3M 0.14%
193,870
+43,021
+29% +$3.99M
BMY icon
142
Bristol-Myers Squibb
BMY
$131B
$18.2M 0.14%
264,221
+5,890
+2% +$389K
BAP icon
143
Credicorp
BAP
$29.9B
$18.2M 0.14%
186,638
+46,450
+33% +$5.04M
MRK icon
144
Merck
MRK
$357B
$18.1M 0.14%
359,728
-739,191
-67% -$37.3M
IONS icon
145
Ionis Pharmaceuticals
IONS
$8.55B
$17.9M 0.14%
289,544
+24,350
+9% +$1.31M
ABBV icon
146
AbbVie
ABBV
$454B
$17.3M 0.14%
291,565
+9,932
+4% +$572K
SHPG
147
DELISTED
Shire pic
SHPG
$16.9M 0.13%
82,650
+16,341
+25% +$3.4M
LLY icon
148
Eli Lilly
LLY
$1.01T
$16.9M 0.13%
200,342
+11,473
+6% +$952K
AZN icon
149
AstraZeneca
AZN
$254B
$16.6M 0.13%
243,761
+12,421
+5% +$814K
RUN icon
150
Sunrun
RUN
$2.01B
$16.5M 0.13%
1,403,900
-34,000
-2% -$310K
4 5
6
7 8

Similar funds

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
National Pension Service
National Pension Service Jeonju-Si, Jeollabuk-Do, South Korea $155B AUM 42.54% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

VanEck Associates's Q4 2015 Portfolio in Review

As of Q4 2015, VanEck Associates held 834 positions worth $12.6B, down 3.1% from $13B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

VanEck Associates's Q4 2015 filing shows 37 new, 442 increased, 281 reduced and 71 closed positions. Its largest new stake was Kansas City Southern: 460,194 shares worth $34.4M. The largest sale was Cummins, an estimated $78.5M.

By sector, the portfolio is most concentrated in Materials at 43% of assets, down from 43% a quarter earlier, followed by Energy and Healthcare.

  • VanEck Associates's largest Q4 2015 buy was Kansas City Southern: 460,194 shares worth $34.4M.
  • VanEck Associates added most to CF Industries in Q4 2015, an estimated $88.6M increase.
  • VanEck Associates's biggest Q4 2015 reduction was Cummins, cutting an estimated $78.5M.
  • VanEck Associates fully exited Procter & Gamble in Q4 2015, selling an estimated $39.7M.
  • VanEck Associates's ten largest holdings make up 25% of its $12.6B portfolio in Q4 2015.
  • VanEck Associates opened 37 new positions and closed 71 in Q4 2015.
  • VanEck Associates's portfolio value fell 3.1% quarter-over-quarter to $12.6B.

Based on VanEck Associates's 13F filing for Q4 2015, filed 12 Feb 2016.